Lumos Pharma, Inc. Common Stock
LUMO
LUMO was delisted on the 11th of December, 2024.
94 hedge funds and large institutions have $394M invested in Lumos Pharma, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 9 closing their positions.
136% more call options, than puts
Call options by funds: $32.5M | Put options by funds: $13.8M
122% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 9
77% more capital invested
Capital invested by funds: $223M → $394M (+$171M)
44% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 25
13% more funds holding
Funds holding: 83 → 94 (+11)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$78.6M |
| 2 |
State Street
Boston,
Massachusetts
|
+$19.5M |
| 3 |
First Eagle Investment Management
New York
|
+$8.72M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$8.27M |
| 5 |
PC
PointState Capital
New York
|
+$7.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$12.1M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.67M |
| 3 |
Barclays
London,
United Kingdom
|
-$3.56M |
| 4 |
TAM
Tiverton Asset Management
Wilimington,
Delaware
|
-$3.4M |
| 5 |
WSA
Wall Street Associates
Lajolla,
California
|
-$2.68M |
LUMO Hedge Fund Activity: Q1 2014 in Review
94 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q1 2014, worth a combined $394M — up 77% from $223M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new LUMO positions and 9 closed out — a net gain of 11 holders — while 36 added to existing stakes and 25 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $78.6M. The largest seller was Millennium Management, exiting entirely with an estimated $12.1M sold.
- 94 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q1 2014, up from 83 in Q4 2013.
- Funds reported $394M of Lumos Pharma, Inc. Common Stock stock for Q1 2014, up 77% quarter-over-quarter.
- 20 funds opened new Lumos Pharma, Inc. Common Stock positions in Q1 2014 and 9 closed out, a net change of +11 holders.
- The largest Lumos Pharma, Inc. Common Stock buyer in Q1 2014 was Fidelity Investments, an estimated $78.6M added.
- The largest Lumos Pharma, Inc. Common Stock seller in Q1 2014 was Millennium Management, an estimated $12.1M sold.
Based on aggregated 13F filings for Q1 2014.